Design and analysis of bioavailability and bioequivalence studies / Shein-Chung Chow, Jen-pei Liu
Material type: TextSeries: Chapman & Hall/CRC biostatistics series ; 27Publication details: Boca Raton : CRC Press, c2009Edition: 3rd edDescription: xxii, 733 p. : ill. ; 25 cmISBN:- 9781584886686 (hardback : alk. paper)
- 1584886684 (hardback : alk. paper)
- 615.7
- RM301.6 .C46 2009
- RM301.6 .C46 2009
Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
Books | Centeral Library Second Floor - Pharmacy | 615.7 C.H.D 2009 (Browse shelf(Opens below)) | Available | 12742-1 |
Browsing Centeral Library shelves, Shelving location: Second Floor - Pharmacy Close shelf browser (Hides shelf browser)
615.7 B.L.A 2008 Applied clinical pharmacokinetics | 615.7 B.L.A 2008 Applied clinical pharmacokinetics | 615.7 B.L.A 2008 Applied clinical pharmacokinetics | 615.7 C.H.D 2009 Design and analysis of bioavailability and bioequivalence studies / | 615.7 E.M.A 2006 Applied pharmacokinetics & pharmacodynamics : | 615.7 E.M.A 2006 Applied pharmacokinetics & pharmacodynamics : | 615.7 G.L.G 2006 Goodman & Gilman's the pharmacological basis of therapeutics |
Includes bibliographical references (p. 647-667) and index
Design of bioavailability studies -- Statistical inferences for effects from a standard 2x2 crossover design -- Statistical methods for average bioequivalence -- Power and sample size determination -- Transformation and analysis of individual subject ratios -- Assessment of inter- and intra-subject variabilities -- Assumptions of outlier detection for average bioequivalence -- Optimal crossover designs for two formulations for average bioequivalence -- Assessment of bioequivalence for more than two formulations -- Population and individual bioequivalence -- Statistical procedures for assessment of population and individual bioequivalence -- Assessment of bioequivalence for drugs with negligible plasma levels -- In vitro bioequivalence testing -- In vitro dissolution profiles comparison -- Meta-analysis for bioequivalence review -- Population pharmacokinetics -- Other pharmacokinetic studies -- Review of regulatory guidances on bioequivalence -- Frequently asked questions and future challenges
There are no comments on this title.